|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of Dose Rate and Mixtures of Fungicides on Selection for QoI Resistance in Populations of Plasmopara viticola显示文摘 | JEAN-LUC G GRAZYNA J FRANCINE D | 2006 | Pest Manag Sci2006，62，： | 1 |
| 2 | Characterization of binding of Candida albicans to small Intestinal mucin and its role in adherence to mucosal epithelial cells显示文摘 | Louis D R Francine A Karine B | 2000 | Infect Immun2000，68，6： | 1 |
| 3 | Leishmania major and HIV co-infection in Burkina Faso显示文摘 | Robert T. Guiguemdé Oumar S. Sawadogo Christian Bories Kadidiatou L. Traore Désiré Nezien Laetitia Nikiema Francine Pratlong Pierre Marty René Houin Michele Deniau | 2003 | Transactions of the Royal Society of Tropical Medicine and Hygiene2003，，2： | 1 |
| 4 | Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice显示文摘 | Christopher L Bradley C G Francine S F Carolyn A W David E O Bernhard J H Zhifeng L Edward O Bruce E T Daniel R S | 2000 | Nature2000，407，： | 1 |
| 5 | Association of fine particulate matter from different sources with daily mortality in six US cities显示文摘 | Francine Ln Neas L M Dockery D W | 2000 | Environmental Health Perspectives2000，108，： | 1 |
| 6 | Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy显示文摘 | Zhao Min Célérier Isabelle Bousquet Elodie Jeanny Jean-Claude Jonet Laurent Savoldelli Michèle Offret Olivier Curan Antoine Farman Nicolette Jaisser Frédéric Behar-Cohen Francine | 2012 | EN2012，，7： | 1 |
| 7 | Diffusion tensor imaging of partial intractable epilepsy显示文摘 | Anne Dumas de la Roque Catherine Oppenheim Francine Chassoux Sebastian Rodrigo Frédéric Beuvon Catherine Daumas-Duport Bertrand Devaux Jean-Fran?ois Meder | 2005 | European Radiology2005，，2： | 1 |
| 8 | Synthesis of photocross-linkable fluorinated polydimethylsiloxanes:Direct introduction of acrylic pendant groups via hydrosilylation显示文摘 | Bernard Boutevin Francine Guida-Pietrasanta Amédée Ratsimihety | 2000 | J Polym Sci Part A:Polym Chem2000，38，20： | 1 |
| 9 | Characterization of bifidobacteria by random DNA amplification显示文摘 | Daniel Vincent Denis Roy Francine Mondou Claude Déry | 1998 | International Journal of Food Microbiology1998，，3： | 1 |
| 10 | DRIS-based fertilization efficiency of young hybrid poplar plantations in the boreal region of Canada显示文摘 | Ra?d Elferjani Annie DesRochers Francine Tremblay | 2013 | New Forests2013，，4： | 1 |
| 11 | Three additional phthalide derivatives, an epoxymonomer and two dimmers,from Ligustilicum wallichii rhizomes 显示文摘 | Kaouadji M Francin D P Corinne P | 1986 | J Nat Prod1986，49，5： | 1 |
| 12 | FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study显示文摘BACKGROUND FOLFIRINOX regimen is the first-line reference chemotherapy(L1)in advanced pancreatic ductal adenocarcinoma(aPDAC).FOLFOXIRI,a schedule with a lower dose of irinotecan and no bolus 5-fluorouracil,has demonstrated efficacy and feasibility in colorectal cancer.AIM To investigate the potential clinical value of FOLFOXIRI in patients with aPDAC in routine clinical practice.METHODS Analyses were derived from all consecutive aPDAC patients treated in L1 between January 2011 and December 2017 in two French institutions,with either FOLFOXIRI(n=165)or FOLFIRINOX(n=124)regimens.FOLFOXIRI consisted of irinotecan(165 mg/m2),oxaliplatin(85 mg/m2),leucovorin(200 mg/m2)and 5-fluorouracil(3200 mg/m2 as a 48-h continuous infusion)every 2 wk.Ninety-six pairs of patients were selected through propensity score matching,and clinical outcomes of the two treatment regimens were compared.RESULTS Median overall survival was 11.1 mo in the FOLFOXIRI and 11.6 mo in the FOLFIRINOX cohorts,respectively.After propensity score matching,survival rates remained similar between the two regimens in terms of overall survival(hazard ratio=1.22;P=0.219)and progression-free survival(hazard ratio=1.27;P=0.120).The objective response rate was 37.1%in the FOLFOXIRI group vs 47.8%in the FOLFIRINOX group(P=0.187).Grade 3/4 toxicities occurred in 28.7%of patients in the FOLFOXIRI cohort vs 19.5%in the FOLFIRINOX cohort(P=0.079).FOLFOXIRI was associated with a higher incidence of grade 3/4 digestive adverse events.Hematopoietic growth factors were used after each chemotherapy cycle and the low hematological toxicity rates were below 5%with both regimens.CONCLUSION FOLFOXIRI is feasible in L1 in patients with aPDAC but does not confer any therapeutic benefit as compared with FOLFIRINOX.The low hematological toxicity rates strengthened the relevance of primary prophylaxis with hematopoietic growth factors. | Angélique Vienot Hortense Chevalier Clément Bolognini Elisabeta Gherga Elodie Klajer Aurélia Meurisse Marine Jary Stefano Kim Christelle d’Engremont Thierry Nguyen Fabien Calcagno Hamadi Almotlak Francine Fein Meher Nasri Syrine Abdeljaoued Anthony Turpin Christophe Borg Dewi Vernerey | 2020 | World Journal of Gastrointestinal Oncology2020，12，3： | 0 |
| 13 | 私藏的七彩时光 | Carl D'Aquino Francine Monaco Peter Murdock 肖俊 | 2012 | 现代装饰(家居)2012，0，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员